Editorial: Let your muscles do the talking-what can muscle quality tell us about hepatic fibrosis?

被引：2
作者：
Petroff, David [1 ,4 ]
Wiegand, Johannes [2 ]
Karlas, Thomas [3 ]
机构：
[1] Univ Leipzig, Clin Trial Ctr, Leipzig, Germany
[2] Univ Leipzig, Dept Med 2, Div Hepatol, Med Ctr, Leipzig, Germany
[3] Univ Hosp Leipzig, Dept Med 2, Div Gastroenterol, Leipzig, Germany
[4] Univ Leipzig, Clin Trial Ctr, Haertelstr 16-18, D-04017 Leipzig, Germany
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 58卷 / 03期
关键词：
D O I：
10.1111/apt.17618
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：372 / 373
页数：2
相关论文
共 10 条
[1]   Review article: prognostic significance of body composition abnormalities in patients with cirrhosis [J].
Ebadi, Maryam ;
Bhanji, Rahima A. ;
Tandon, Puneeta ;
Mazurak, Vera ;
Baracos, Vickie E. ;
Montano-Loza, Aldo J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (04) :600-618
[2]   Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B [J].
Han, E. ;
Lee, Y. -H. ;
Kim, B. K. ;
Park, J. Y. ;
Kim, D. Y. ;
Ahn, S. H. ;
Lee, B. -W. ;
Kang, E. S. ;
Cha, B. -S. ;
Han, K. -H. ;
Kim, S. U. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (03) :300-312
[3]   Muscle fat contents rather than muscle mass determines nonalcoholic steatohepatitis and liver fibrosis in patients with severe obesity [J].
Han, Eugene ;
Kim, Mi Kyung ;
Lee, Hye Won ;
Ryu, Seungwan ;
Kim, Hye Soon ;
Jang, Byoung Kuk ;
Suh, Youngsung .
OBESITY, 2022, 30 (12) :2440-2449
[4]   Myosteatosis, but not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression [J].
Hsieh, Yun-Cheng ;
Joo, Sae Kyung ;
Koo, Bo Kyung ;
Lin, Han-Chieh ;
Lee, Dong Hyeon ;
Chang, Mee Soo ;
Park, Jeong Hwan ;
So, Young Ho ;
Kim, Won .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (02) :388-+
[5]   Low-quality muscle mass rather than normal-quality muscle mass determines fibrosis progression in biopsy-proven NAFLD [J].
Lee, Yun Kyu ;
Koo, Bo Kyung ;
Joo, Sae Kyung ;
Lee, Dong Hyeon ;
Jang, Heejoon ;
Chai, Jee Won ;
Lee, Myoung Seok ;
Jang, Si Won ;
So, Young Ho ;
Park, Jeong Hwan ;
Chang, Mee Soo ;
Kim, Won .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (03) :322-333
[6]   An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography [J].
Liang, Jia-xu ;
Ampuero, Javier ;
Niu, Hao ;
Imajo, Kento ;
Noureddin, Mazen ;
Behari, Jaideep ;
Lee, Dae Ho ;
Ehman, Richard L. ;
Rorsman, Fredrik ;
Vessby, Johan ;
Lacalle, Juan R. ;
Mozes, Ferenc E. ;
Pavlides, Michael ;
Anstee, Quentin M. ;
Harrison, Stephen A. ;
Castell, Javier ;
Loomba, Rohit ;
Romero-Gomez, Manuel .
JOURNAL OF HEPATOLOGY, 2023, 79 (03) :592-604
[7]   Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD [J].
Linge, Jennifer ;
Ekstedt, Mattias ;
Leinhard, Olof Dahlqvist .
JHEP REPORTS, 2021, 3 (01)
[8]   AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults [J].
Nachit, Maxime ;
Horsmans, Yves ;
Summers, Ronald M. ;
Leclercq, Isabelle A. ;
Pickhardt, Perry J. .
RADIOLOGY, 2023, 307 (05)
[9]   Sarcopenia, More Than Just Muscle Atrophy: Imaging Methods for the Assessment of Muscle Quantity and Quality [J].
Nikodinovska, Violeta Vasilevska ;
Ivanoski, Slavcho .
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2023, 195 (09) :777-789
[10]   Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease [J].
Petta, S. ;
Ciminnisi, S. ;
Di Marco, V. ;
Cabibi, D. ;
Camma, C. ;
Licata, A. ;
Marchesini, G. ;
Craxi, A. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (04) :510-518
1